About Careers Internship MedBlog Contact us

'Lewy Bodies' Spread Hope for Treatment of Parkinson's

by Dr. Enozia Vakil on March 4, 2013 at 11:47 AM
 'Lewy Bodies' Spread Hope for Treatment of Parkinson's

Erratic gene may cause build-up of proteins in key brain cells, leading to Parkinson's, study.

Parkinson's patients suffer from progressive stiffness, slowing of movement and problems in coordination resulting from the loss of nerve cells that make a muscle-controlling chemical, dopamine.


A hallmark of the disease is the presence of so-called Lewy bodies, an accumulation of toxic proteins in these vital cells.

But how the proteins -- the byproducts of normal cellular processes -- are allowed to pile up within the cell, eventually killing it, has remained unclear.

Researchers at the Einstein College of Medicine in New York took a close look at a gene that controls a dogsbody molecule called leucine-rich repeat kinase-2, or LRRK2.

A flawed version of the LRRK2 gene has already been fingered, along with other genetic culprits, as being among the inherited causes of Parkinson's.

Delving into this association, the team discovered that a faulty LRRK2 gene turns out an abnormal protein that blocks the task of clearing out the junked-up cell.

"Our study found that abnormal forms of LRRK2 protein disrupt an important garbage-disposal process in cells that normally digests and recycles unwanted proteins," said Ana Maria Cuervo, a professor of developmental and molecular biology.

One of the big pieces of junk is alpha-synuclein, which "accumulates to toxic levels in nerve cells" when LRRK2 prevents a cleanup, she said.

The investigators, publishing in the journal Nature Neuroscience, tested the theory on tissue from lab mice; on brain cells taken from Parkinson's patients who have the LRRK2 mutation; and on brain cells that had been reprogrammed from skin cells taken from other individuals with Parkinson's.

One option now is to look for drugs that sidestep the LRRK2's brake on cellular clearout, the paper said.

"We are now looking at ways to enhance the activity of this recycling system to see if we can prevent or delay neuronal death and disease," Cuervo said in a press release.

"We've started to analyse some chemical compounds that look very promising."

Source: AFP
Font : A-A+



Latest Mental Health News

How is Schizophrenia Genetically Linked to Cardiovascular Risk Factors?
Schizophrenic patients have a genetic link to increased cardiovascular risk factors, especially smoking and body mass index.
Anxiety & Depression - Early Hints to Multiple Sclerosis
Mental health issues such as anxiety and depression could be precursors to multiple sclerosis (MS), even before the classic MS symptoms appear.
Predicting PTSD Resilience Through Post Traumatic Brain Activity
Studying brain circuits tied to PTSD's progression from acute to chronic states is vital for grasping its pathophysiology and crafting targeted treatments.
High Depression Rates Among Canadian COPD Patients During COVID-19
Older adults with COPD were roughly twice as likely to develop depression if they faced functional limitations.
Comparing Suicide Risk and Depression Screenings for Identifying Patient Risk
In most scenarios, depression screening tools demonstrated superior performance compared to suicide risk screenings.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

'Lewy Bodies' Spread Hope for Treatment of Parkinson's Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests